Cited by 73Inflammatory Bowel DiseaseGut microbiota and healthClostridium difficile and Clostridium perfringens research

Systematic review of donor and recipient predictive biomarkers of response to faecal microbiota transplantation in patients with ulcerative colitis

Open access
Rees, Nia Paddison, Shaheen, Walaa, Quince, Christopher, Tselepis, Chris, Horniblow, Richard D, Sharma, Naveen, Beggs, Andrew D, Iqbal, Tariq H +1 more·2022·EBioMedicine

Abstract

BACKGROUND: Faecal microbiota transplantation (FMT) has previously been explored as a treatment for ulcerative colitis (UC) however, biomarkers that predict and / or are associated with clinical response are poorly defined. The aim of this systematic review was to identify donor and recipient clinical, microbial and metabolomic predictive biomarkers of response to FMT in UC. METHODS: A systematic search of the relevant literature of studies exploring FMT in UC was conducted. Data on microbial diversity, taxonomic changes, metabolic changes, donor and recipient microbiota relationship and baseline predictors was examined. FINDINGS: 2852 studies were screened, and 25 papers were included in this systematic review. Following FMT, alpha diversity was seen to increase in responders along with increases in the abundance of Clostridiales clusters (order) and Bacteroides genus. Metabolomic analysis revealed short chain fatty acid (SCFA) production as a marker of FMT success. Donors or FMT batches with higher microbial alpha diversity and a greater abundance of taxa belonging to certain Bacteroides and Clostridia clusters were associated with clinical response to FMT. Baseline clinical predictors of response in patients with UC included younger age, less severe disease and possibly shorter disease duration. Baseline recipient microbial predictors at response consisted of higher faecal species richness, greater abundance of Candida and donor microbial profile similarity. INTERPRETATION: Distinct changes in gut microbiota profiles post-FMT indicate that certain baseline characteristics along with specific microbial and metabolomic alterations may predispose patients towards a successful therapeutic outcome. Opportunities towards a biomarker led precision medicine approach with FMT should be explored in future clinical studies. FUNDING: There no specific funding to declare.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ebiom.2022.104088

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Higher donor alpha diversity was identified as predictive of a response in a systematic review of 25 studies evaluating FMT in patients with UC.

    “More extensively, higher donor alpha diversity was identified as predictive of a response in a systematic review of 25 studies evaluating FMT in patients with UC. 57”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. [19]Sarbagili Shabat C Scaldaferri F Zittan E Use of Fecal transplantation with a novel diet for mild to moderate active ulcerative colitis: The CRAFT UC randomized controlled trial J Crohns Colitis 2021 PMC8919830 34514495
  2. [28]Sood A Singh A Mahajan R Clinical Predictors of response to Faecal Microbiota Transplantation in patients with active ulcerative colitis J Crohns Colitis 2020 32772093

Authors
Rees, N. P., Shaheen, W., Quince, C., Tselepis, C., Horniblow, R. D., Sharma, N., Beggs, A. D., Iqbal, T. H., & Quraishi, M. N.
Affiliations
  • University of Birmingham (GB)
  • Earlham Institute (GB)
  • University Hospitals Birmingham NHS Foundation Trust (GB)
Corresponding author
Quraishi, Mohammed Nabil
Venue
EBioMedicine
Publisher
Elsevier BV
Published
2022-07
Volume
81
Pages
104088
ISSN
2352-3964 (ISSN-L)
OpenAlex
W4281689359
Cited by
73
References
52
Citations by year
2026: 12 · 2025: 28 · 2024: 17 · 2023: 15 · 2022: 1
FWCI
2.38
Type
journal article
Language
en
Open access
Locations
  • EBioMedicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • UEA Digital Repository (University of East Anglia) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • University of Birmingham Research Portal (University of Birmingham) (submittedVersion, cc-by)
  • University of Birmingham Research Portal (University of Birmingham) (submittedVersion, other-oa)
Funders
Engineering and Physical Sciences Research Council (EP/V027743/1)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Inflammatory Bowel Disease
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
Keywords
fecal microbiota transplantation, ulcerative colitis, predictive biomarkers, treatment response, gut microbiota, microbial diversity, short-chain fatty acids, Bacteroides, Clostridiales, Candida, metabolomics, precision medicine
MeSH terms
Gastrointestinal Microbiome, Fecal Microbiota Transplantation, Colitis, Ulcerative, Feces, Humans, Biomarkers, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review